US government exercises option to buy Bavarian smallpox vaccines for USD 119m

The first option in an existing contract with the US has been utilized, and Bavarian Nordic can start manufacturing freeze-dried doses of Jynneos for the country in 2023.
Photo: Bavarian Nordic / PR
Photo: Bavarian Nordic / PR
by albert rønning-andersson, translated by daniel pedersen

The US Biomedical Advanced Research and Development Authority (BARDA), which falls under the US Department of Health and Human Services, has exercised an option in a contract with Danish vaccine firm Bavarian Nordic, the firm has announced in a Wednesday press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading